Abstract
Background: This work showed the use of 0-2D Dragon molecular descriptors in the prediction of α-amylase and α-glucosidase inhibitory activity.
Methods: Several artificial intelligence techniques are used for obtaining quantitative structure-activity relationship (QSAR) models to discriminate active (inhibitor) compounds from inactive (non-inhibitor) ones. The machine learning methodologies such as support vector machine, artificial neural network, and k-nearest neighbor (k-NN) were employed. The k-NN technique had the best classification performances for both targets with values above 90% for the training and prediction sets, correspondingly. Results and Conclusion: These results provided a double target modeling approach for increasing the estimation of antidiabetic chemicals identification aimed by double-way workflow in virtual screenings pipelines.Keywords: α-Amylase, α-glucosidase, classification model, dragon descriptor, machine learning, QSAR.
Letters in Drug Design & Discovery
Title:A Two QSAR Way for Antidiabetic Agents Targeting Using α-Amylase and α-Glucosidase Inhibitors: Model Parameters Settings in Artificial Intelligence Techniques
Volume: 14 Issue: 8
Author(s): Karel Dieguez-Santana*, Hai Pham-The, Oscar M. Rivera-Borroto, Amilkar Puris, Huong Le-Thi-Thu and Gerardo M. Casanola-Martin*
Affiliation:
- Faculty of Life Sciences, Amazonian State University, Paso Lateral km 2½ via Tena, Puyo, Pastaza,Ecuador
- Department of Systems and Computer Engineering, Carleton University, Ottawa, ON,Canada
Keywords: α-Amylase, α-glucosidase, classification model, dragon descriptor, machine learning, QSAR.
Abstract: Background: This work showed the use of 0-2D Dragon molecular descriptors in the prediction of α-amylase and α-glucosidase inhibitory activity.
Methods: Several artificial intelligence techniques are used for obtaining quantitative structure-activity relationship (QSAR) models to discriminate active (inhibitor) compounds from inactive (non-inhibitor) ones. The machine learning methodologies such as support vector machine, artificial neural network, and k-nearest neighbor (k-NN) were employed. The k-NN technique had the best classification performances for both targets with values above 90% for the training and prediction sets, correspondingly. Results and Conclusion: These results provided a double target modeling approach for increasing the estimation of antidiabetic chemicals identification aimed by double-way workflow in virtual screenings pipelines.Export Options
About this article
Cite this article as:
Dieguez-Santana Karel*, Pham-The Hai, Rivera-Borroto M. Oscar, Puris Amilkar, Le-Thi-Thu Huong and Casanola-Martin M. Gerardo*, A Two QSAR Way for Antidiabetic Agents Targeting Using α-Amylase and α-Glucosidase Inhibitors: Model Parameters Settings in Artificial Intelligence Techniques, Letters in Drug Design & Discovery 2017; 14 (8) . https://dx.doi.org/10.2174/1570180814666161128121142
DOI https://dx.doi.org/10.2174/1570180814666161128121142 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antihypertensive Therapy in Children: Differences in Medical Approach Between the United States and Europe
Current Medicinal Chemistry Actinomycetes as a Paramount Source of Biologically Important Enzyme Inhibitors – “A Boon to Mankind”
Current Bioactive Compounds Editorial: [Hot topic: Weight Gain Management and Nutritional Education Throughout Pregnancy (Guest Editor: Hiroko Watanabe)]
Current Women`s Health Reviews Diabetes-induced Epigenetic Signature in Vascular Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice
Cardiovascular & Hematological Disorders-Drug Targets Molecular Genetics and Epidemiology of Japanese Type 1 Diabetes
Current Pharmacogenomics Therapeutic Approaches for Reducing C-Reactive Protein (CRP) Levels and the Associated Cardiovascular Risk
Current Chemical Biology Mouse Models of Primary Sjogren’s Syndrome
Current Pharmaceutical Design The Impact of Substance P on the Pathogenesis of Insulin Resistance Leading to Gestational Diabetes
Current Pharmaceutical Biotechnology Human postnatal Mesenchymal Stem Cell Derived Islets as a Model for Diabetes Research
Current Diabetes Reviews Maternal Nutrition and Predisposition to Later Kidney Disease
Current Drug Targets Coffee: A Selected Overview of Beneficial or Harmful Effects on the Cardiovascular System?
Current Vascular Pharmacology Common Structural Stability Properties of 4-Helical Bundle Cytokines: Possible Physiological and Pharmaceutical Consequences
Current Pharmaceutical Design Epigenetic Modulation: A Promising Avenue to Advance Hematopoietic Stem Cell-Based Therapy for Severe Autoimmune Disorders
Epigenetic Diagnosis & Therapy (Discontinued) Myocardial Infarction with Non Obstructive Coronary Atherosclerosis: A Case Report
New Emirates Medical Journal Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia
Current Drug Safety Effect of Cardioembolic Etiology on Intravenous Thrombolysis Efficacy for Acute Ischemic Stroke
Current Neurovascular Research Isolated Compounds from Natural Products with Potential Antidiabetic Activity - A Systematic Review
Current Diabetes Reviews The Neuropeptide Galanin Benefits Insulin Sensitivity in Subjects with Type 2 Diabetes
Current Protein & Peptide Science Enhanced Proinflammatory State and Autoimmune Activation: a Breakthrough to Understanding Chronic Diseases
Current Pharmaceutical Design